| Identification | Back Directory | [Name]
LXA5 | [CAS]
110657-98-2 | [Synonyms]
LXA5
Lipoxin A5,Lipoxin A-5
ZZMKOZNTEJVKRY-YJUORNCYSA-N
5S,6R,15S-TRIHYDROXY-7E,9E,11Z,13E,17Z-EICOSAPENTAENOIC ACID
7,9,11,13,17-Eicosapentaenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S,17Z)- | [Molecular Formula]
C20H30O5 | [MDL Number]
MFCD11976895 | [MOL File]
110657-98-2.mol | [Molecular Weight]
350.45 |
| Chemical Properties | Back Directory | [Boiling point ]
591.3±50.0 °C(Predicted) | [density ]
1.112±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 1 mg/ml | [pka]
4.67±0.10(Predicted) |
| Hazard Information | Back Directory | [Description]
Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes. LXA5 slowly contracts pulmonary parenchymal strips from guinea pig with similar potency to that of LXA4 and LXB4. However, LXA5 does not exert the vasodilatory effects on aortic smooth muscle exhibited by LXA4 and LXB4. | [Uses]
Lipoxin A5 is a metabolite of EPA with effects similar to LXA4 and LXB4. |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|